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Intra-ocular concentration-time relationships of 
subcon junctivally administered gentamicin 
M. M. B. VAN ROOYEN, J. F. COETZEE, D. F. DU TOIT, P. P. VAN JAARSVELD 
Summary 
Eighty-nine patients scheduled for cataract removal or lens 
implantation were divided randomly into three groups. Each 
received 5, 10 or 20 mg gentamicin subconjunctivally at 
times varying between 0,2 and 19 hours pre-operatively. At 
surgery a sample of aqueous humour was o&tained and 
analysed for gentamicin concentration. The data for each 
group were subjected to non-linear regression analysis to fit 
an oDen one-commrtment ~harmacokinetic model with first- 
ord& kinetics. A  ati is tic ally acceptable fit was obtained. 
The average values of -the pharmacokinetic parameters 
obtained from the sinale doses were used to simulate multi&- 
dose kinetics. The average target intra-ocular gentamkin 
concentrations and dosage interval were specified in the 
computer program, which subsequently allowed calculation 
of the dose required. This allowed the construction of a 
simple linear nomogram that can be used to read off the dose 
needed for handling specific clinical situations. 
S Afr Med J 1991; 80: 236-239. 
The aminoglycoside antibiotic, gentamicin, is a valuable agent 
for treatment of severe bacterial eye infections as well as for 
pre-operative prophylaxis. Its hydrophilic nature pxdudes 
topical application in eye drops as an effective method to 
achieve bactericidal concentrations in the aqueous humour. 
Soft contact lenses soaked with the drug can, however, be used 
successfully because the time allowed for diffusion is lengthened 
considerab1y.l Intravenous and intramuscular injections are 
ineffective routes of administration because of the resulting 
low concentration-gradient ,,r~qu.i<edma~ros~ th5, blovd-ey~ 
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barrier. It is reasonable to assume that the required increased 
gradient for significant diffusion across the barrier would give 
rise to the well-known oto- and nephrotoxie side-effects of the 
aminoglycosides.2 Subconjunctival or retrobulbar injections 
are therefore the preferred methods of administration in order 
to assure adequate concentrations in different tissues of the 
eye. 
Several reports3-'0 have dealt with gentamicin concentra- 
tion-time relationships in the eye after subconjunctival or 
retrobulbar injections. Apart from those in experimental 
the concentrations of gentamicin in humans were 
measured in the aqueous humour, the vitreous humour and 
~ornea.~-~ A high degree of interpatient variation was evident 
in all these studies. Furthermore, diffusion into different 
tissues of the eye is apparently governed by different rate 
constants and consequently no efforts have been made to 
establish on a pharmacokinetic basis a dosing strategy that 
would ensure adequate concentrations in the eye over a specific 
period. 
We have studied the aqueous humour concentrations of 
subconjunctivally injected gentamicin as a function of time 
after single fmed doses in patients elected for eye surgery. The 
data were analysed as a single-dose one-compartment pharma- 
cokinetic model. Simulated concentration-time relationships of 
multidose regimens were constructed using the average 
pharmacokinetic parameters. This enabled us to calculate the 
doses needed at specific intervals in order to achieve an 
average specified target concentration in the aqueous humour. 
We believe that these guidelines can assist the clinician in 
treating different bacterial infections wifh adequate doses and 
dosage intervals. 
Patients scheduled for cataract extraction &or lens implan- 
tation were divided randomly into three groups who received 
5, 10 or 20 mg gentamicin subconjunctivally at times varying 
from 0 2  hours to 19 hours pre-operatively. Each dose was 
administered in 0,5 m1 saline by a team of surgeons who 
followed a similar technique of subconjunctival injection, i.e. 
the conjunctiva was penetrated between the limbus and 10 
mm from the limbus with the needle parallel between the 
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conjunctiva or Tenon's fascia and sclera. The injection was Results given 10 mm from the puncture and allowed to spread without 
much pressure build-up. The area and position of spread was \ Fig. 1 depicts the variation in i n t r a d a r  gentamicin concen- 
tration with time for the 5, 10 and 20 mg doses respectively. 
Each point represents an kdividual (23 eachfor the 5 
and 10 mg doses and 43 for the 20 mg doses). The wide scatter 
is obviously related to interpatient variation. Nevertheless a 
statistically acceptable fit for each dose was obtained, as shown 
by the Alkaike, Schwsuz, r- and P-values summarised in Table 
T 
noted. 
The age of the 89 patients used in this study varied from 54 
years to 88 years (mean 70 years). 
At surgery a sample of 50 p1 aqueous humour was obtained 
and analysed within 3 hours for gentamicin concentration by 
enzyme-mediated immunotechnology (EMIT, Syva, Palo Alto, 
California, USA). Appropriate controls and standards were 
run with each patient sample in order to ensure maximum 
accuracy and minimum day-to-day and batch variation. 
The data from each group was treated as a one-compartment 
open pharmacokinetic model with fmt-order absorption and 
elimination: 
ka gentamicin ke 
&F - concentration in - 
aqueous humour 
Variation in concentration of gentamicin in intra-ocular fluid 
(C) with time (t) is described by the expression: 
where & = dose 
F = fraction of drug absorbed 
k, = absorption rate constant 
ke = elimination rate constant 
Vd = volume of distribution. 
Non-hear regression analysis for each data set at a f ~ e d  
dose was performed using the program STATIS 2 (Clydesoft 
Statistical and ScienMic Software, Larkhall, UK). The Akaike 
information criterion and Schwarz value were used as measures 
of good fit while P-values and correlation coefficients (r) were 
calculated according to standard statistical  method^.".'^ 
Standard equations derived from pharmacokinetic theory13'14 
were used to calculate elimination half-life (tx) in hours, 
clearance (Cl) in mVh, volume of distribution (Vd) in m1 and 
area under the concentration time curve (AUC) in pg/ml/h. 
A computer simulation program based on the average values 
of the parameters of the pharmacokinetic model obtained for 
the three single doses (5, 10 and 20 mg) was written in 
TURBO BASIC in order to estimate various dosing strategies 
according to standard theory of multiple-dose pharmacokine- 
tiCS.13.14 The program enabled us to specify an average target 
intra-ocular gentamicin concentration and the dosage interval 
in hours with subsequent calculation of the required dose and 
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Fig. 1. Variation of intra-ocular gentamicin concentration with 
time after single subconjunctival doses of 5, 10 and 20 mg. Each 
point represents the value found in a patient's aqueous humour. 
The curves represent the best fit of an $pen single-compartment 
pharmacokinetic model. 
. = .. 
TABLE I. RESULTS OF PHARMACOKINETIC MODELLING OF THE DATA SHOWN IN FIG- 1 ( c- 
Dose (mg) 
5 10 20 Mean f SD 
Ke ( l  h) 0,239 0,216 0,393 0,283 k 0,079 
Ka ( l  h) 0,847 0,657 0,433 0,646 f 0,169 
tH (h) 2 3  392 1,77 2,623 f 0,616 
Cl/ F (dlh)  183,O 209,O 172,O 188,OO + 15,513 
VdIF (ml) 770.0 965,O 437,O 724,000 f 21 7,995 
AUC (0 +m) 27,4 47,8 116,6 
Akaike value 97,7 135,O 342,O 191,567 f 107,457 
Schwan value 101,O 138,O 347,o . 195,333 + 108,303 
r-value 0,603 0,563 0,646 0,604 + 0,034 
Pvalue < 0,Ol < 0,Ol < 0,001 
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Fig. 2 shows a linear relationship between the AUC and the 
three doses employed (r = 0,W). It is clear that fwt-order 
elimination kinetics was followed for the three doses used and 
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Fig. 2. Correlation of AUC with dose. 
Fig. 3 shows computer simulated curves where the average 10 
target inua-ocular gentamicin concentration was set at 10 
&ml and the dosage intervals at 8, 12 and 24 hours. It is 
evident that the difference between maximum (peak) and 24 48 
minimum (trough) concentrations is the largest at the 24-hour TI ME (HOURS) 
dosage interval and that it decreases with smaller dosage 
intervals. Similarly, the maintenance dose decreases linearly FU. 3. ~ m p u l e r p u l e r ~ u ~ ~  mncentraa-time d-ips for 
because of the first-order kinetics. The time to peak wncentra- 8,12 and 24-hourly dosage schedule cafcuhtdd from standard 
equations m which We average values tions also remains constant for the different dosage inte~als. 
~ t h c ~ r a m e S ~ p h a r m a c o I r ' ~ c  model h The calculated values are summarised in Table I1 for the TaMe l used. 
different dosage intervals. 
,*a 
TABLE II. VALUES OF PEAK AND MINIMUM CONCENTRA- 
TIONS, MAINTENANCE DOSE AND TIME TO PEAK CON- 
CENTRATION CALCULATED FROM COMPUTER-SIMULATED 
CURVES WHERE AN AVERAGE TARGET INTRA-OCULAR 
CONCENTRATION OF 10 fig/ml GENTAMICIN AND THE 
DOSE INTERVAL ARE SET (FIG. 3) 
Dose interval (h) 
24 12 8 
Peak concentration (pg/mi) 40.41 21.08 15,46 
M i i u m  concentration (fig/ml) 0,14 2,07 4,45 
Maintenance dose (mg) 49,17 24,59 16,39 
Time to peak concentration (h) 1,84 1,81 1,74 
Discussion 
Normally the pharmacokinetic behaviour of a drug is deter- 
mined by using concentration-time relationships obtained from 
a series of samples from one individual. Data of this nature 
can, however, not be obtained from the eyes of human patients. 
We therefore used a sample of individual patients to obtain 
anal ysable data. 
To test the linearity of the system, three different doses 
were em~loved. The simplest models providing acceptable 
fitting were open, single-compamnent models with first-order 
eiimination kinetics (Fig. 2, Table I). 
The amputer-simulated c u ~ e s  for multiple-dose regimens 
(Fig. 3) assume that the elimination kinetics of gentamicin 
remain first order. This is a reasonable assumption within the 
limits of the doses calculated to obtain the maximum average 
target concentration of 10 pg/ml because it is well known that 
the aminoglywsides are excreted largely in unaltered forrn.2 
However, selective distribution and attainment of equilibrium 
of the antibiotic in different tissues of the eye may alter the 
model with time into a multicompartment one: It has, for 
instance, been shown that rerrobulbar injection of gentamicin 
resulted in lower doncentrations in the cornea of rabbit eyes 
than the subconjunctival roufe.1° 
We feel that the simulations of multiple-dose regimens are 
of clinical value as they provide guidelines for the concentra- 
tions that can be expected in the aqueous humour bearing in 
mind that the minimum inhibitory concentration of gentamicin 
ranges from 2 &m1 to 10 &ml for different bacteria.I5 
Fig. 4 illustrates that the first-order character of the pharma- 
cokinetic model results in a linear -onship between the 
dose and the average target intra-ocular cmcentrations for 
different dosage schedules. The choice of dosage schedule is 
dictated by the accepted difference between maximum (peak) 
and minimum (trough) concentrations (Fig. 3). The smallest 
difference is obtained using an &hour dosage regimen, while 
the 24hour dosage schedule allows the gentamicin levels to 
fall below the minimum inhibitory concentration for most 
bacteria (Table 11). These considerations together with the use 

